In this articleSections · 10
Executive summary
AI assistants may help Saudi healthcare teams with administrative support, documentation and evidence retrieval. Start with the intended use: each use case needs its own evidence and boundaries. Check SFDA medical-device scope and PDPL health-data rules, then decide from evidence gathered in a controlled local evaluation.
AI assistants can draft, organize and retrieve information around care. Each use case needs its own evidence and boundaries. An administrative assistant, a note-writing tool and software that prioritizes medical images carry different risks and regulatory questions.
Reviewed 2 October 2026. This article describes potential uses and a review process; it does not establish clinical effectiveness or adoption across Saudi hospitals.
Start with the intended use
Write down what the tool does, who uses it, and which decision it can influence. An appointment reminder has a different intended use from a tool that identifies disease or prioritizes a suspected critical finding.
SFDA's MDS-G010 guidance addresses AI/ML medical devices and explains how intended use determines regulatory treatment. Uses such as diagnosis, monitoring, treatment or management of a medical condition can bring a product into medical-device scope. Where applicable, check classification, marketing authorization and clinical evidence before use. Calling the product an “assistant” or adding human review does not settle those questions.
Separate the workflows
Administrative support
Intake-completion checks, appointment reminders, staff handoff drafts and routing a booking request are useful candidates for a bounded evaluation. Use approved templates, collect only necessary data and give staff a clear correction path. Route clinical or urgent questions to a qualified person; do not let a booking assistant assess clinical urgency on its own.
Documentation and evidence retrieval
A scribe can produce a draft from permitted source material. The responsible clinician must check identities, medications, omissions and invented details before the note enters the record. Review recording permissions, storage, provider access and retention before collecting audio.
An evidence assistant should link to the actual guideline or paper and its date. A plausible answer or citation is not enough: check that the source exists, supports the statement and fits the patient and local practice. Measure editing and verification time alongside drafting time.
Imaging and clinical predictions
Imaging prioritization and disease-risk prediction require a separate clinical and regulatory assessment. Verify the product's authorized intended use, assess performance on the relevant population and workflow, and define who responds to missed findings or false alerts. A successful administrative pilot does not validate a clinical tool.
Operations forecasting
Forecasting appointment volume or staffing demand may help planning. Compare it with a simple baseline, document uncertainty and check whether the inputs include patient or other personal data. Accuracy and useful operational decisions must be demonstrated locally.
Patient data needs a separate review
Health data is sensitive under the Saudi PDPL. Article 23 limits health-data access and processing to the minimum staff and extent needed for the relevant services. The Implementing Regulation adds health-data safeguards in Article 26 and requires a documented impact assessment for sensitive-data processing in Article 25.
Before a pilot, map the lawful basis, privacy information, access, recordings, logs, deletion, processors and processing locations. Assess any overseas processing or support access and the applicable health-sector rules. A local cloud region or a patient's consent alone does not establish full compliance.
A practical 90-day evaluation
Treat this as an illustrative planning sequence. Required approvals, technical work or clinical validation can take longer.
- Define and approve the scope. Choose one workflow, a responsible clinical or operational owner, measurable success and stop conditions. Complete privacy, security and regulatory assessments before real patient processing.
- Test with synthetic or appropriately protected examples. Check Arabic and English, missing information, wrong-patient risks, unsupported outputs and escalation. Removing a name alone does not establish anonymization.
- Run a controlled evaluation where authorized. Limit users and data, preserve the existing care route, review outputs and record errors.
- Decide from evidence. Compare net staff time, correction rate, missed escalations, privacy incidents and service quality against a baseline. Scale only after the relevant owners approve the results.
Keep the boundaries visible
Tell staff what the tool can do, which source it used and when to stop relying on it. Provide a human contact, correction and incident reporting. Reassess after model, prompt, integration or intended-use changes.
The useful question is whether a particular tool improves a particular workflow safely. Regulatory guidance explains assessment requirements; it does not prove that a tool saves time, speeds diagnosis or improves patient outcomes.
Related reading
Common questions
Is an AI tool used in a Saudi hospital regulated as a medical device?
It may be, depending on its intended use. SFDA's MDS-G010 guidance addresses AI/ML medical devices and explains how intended use determines regulatory treatment. Uses such as diagnosis, monitoring, treatment or management of a medical condition can bring a product into medical-device scope. Where applicable, check classification, marketing authorization and clinical evidence before use. Calling it an "assistant" or adding human review does not settle those questions.
What does the Saudi PDPL say about health data used by AI tools?
Health data is sensitive under the Saudi PDPL. Article 23 limits health-data access and processing to the minimum staff and extent needed for the relevant services. The Implementing Regulation adds health-data safeguards in Article 26 and requires a documented impact assessment for sensitive-data processing in Article 25. A local cloud region or a patient's consent alone does not establish full compliance.
Can an AI booking assistant decide if a patient's case is urgent?
Not on its own. Do not let a booking assistant assess clinical urgency on its own, and route clinical or urgent questions to a qualified person. Administrative tasks such as appointment reminders, intake-completion checks and routing a booking request are useful candidates for a bounded evaluation, using approved templates, only necessary data and a clear correction path for staff.
How do you evaluate an AI assistant in Saudi healthcare in 90 days?
Pick one workflow and treat 90 days as an illustrative planning sequence. Define the scope, a responsible clinical or operational owner, measurable success and stop conditions, and complete privacy, security and regulatory assessments before real patient processing. Test with synthetic or appropriately protected examples in Arabic and English, run a controlled evaluation where authorized, then compare net staff time, correction rate and missed escalations against a baseline. Approvals or validation can take longer.